54741_Image_jpeg.jpg
Caleb DesRosiers, JD, MPA Appointed to Daxor Corporation Board of Directors
21 janv. 2022 08h00 HE | Daxor Corporation
Oak Ridge, TN, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announced today that it has appointed Caleb DesRosiers, JD,...
54741_Image_jpeg.jpg
Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
06 janv. 2022 08h00 HE | Daxor Corporation
Oak Ridge, TN, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that CEO and President Michael Feldschuh...
54741_Image_jpeg.jpg
Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test for Optimal Heart Failure Management at Key Scientific Society Meeting
16 nov. 2021 08h00 HE | Daxor Corporation
Two New Studies Presented at the American Heart Association Scientific Sessions 2021, Adoption of Technology Reported as “Excellent” and “Valuable” by Lead Authors Oak Ridge, TN, Nov. 16, 2021 ...
54741_Image_jpeg.jpg
Daxor Corporation Receives $200K Matching Fund Award from Launch Tennessee
01 oct. 2021 08h30 HE | Daxor Corporation
The SBIR/STTR Matching Fund Grant Will Advance the Company’s Innovation and Commercialization Efforts, and Job Creation Oak Ridge, TN, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE:...
54741_Image_jpeg.jpg
Daxor Corporation To Present Compelling New Data and Clinical Trials Utilizing the BVA-100® Blood Test at the Heart Failure Society of America Annual Scientific Meeting 2021
08 sept. 2021 08h30 HE | Daxor Corporation
Oak Ridge, TN, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, , today announced it will exhibit at the Heart Failure...
54741_Image_jpeg.jpg
Daxor Corporation to Present at the Summer Solstice - Best Ideas from the Buy Side Conference on June 2, 2021
28 mai 2021 08h30 HE | Daxor Corporation
NEW YORK, May 28, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that Michael Feldschuh, Daxor’s President and...